Analysed HCW BIOLOGICS INC (HCWB:NASDAQ) News Sources
HCW Biologics Reports Fourth Quarter 2025 and Fiscal Year 2025 Business Highlights and Financial Results
31-03-2026
yahoo.com
HCW Biologics Closes Exclusive Worldwide License for HCW11-006 – A High Potential Fusion Immunotherapeutic
17-03-2026
yahoo.com
HCW Biologics Announces Positive Research Results for CAR-T Cell Therapy Manufactured Utilizing Its Commercial-Ready Proprietary Compound, HCW9206, Published in Science Advances
16-03-2026
yahoo.com
HCW Biologics Regains Compliance with All Continued Listing Rules for Nasdaq Per Nasdaq Determination Letter
02-03-2026
yahoo.com
Alopecia Areata Market Set to Expand by 2036, Due to the Emergence of Novel Drug Classes Such as OX40L Inhibitors, IL-2 Inhibitors, IL-7Rα, and Others | DelveInsight
19-02-2026
yahoo.com
HCW Biologics Announces Pricing of $1.5 Million Follow-On Offering Priced At-The-Market Under NASDAQ Rules
18-02-2026
yahoo.com
HCW Biologics and WY Biotech Announce Closing of First Round of Financing For Newly Formed Joint Venture Trimmune
13-02-2026
yahoo.com
HCW Biologics Enters into $4.0 Million Warrant Inducement Priced At-the-Market Under Nasdaq Rules
19-11-2025
yahoo.com
What is the current price of HCW BIOLOGICS INC (HCWB:NASDAQ)?
The current price of HCW BIOLOGICS INC (HCWB:NASDAQ) is $0.437.
HCW BIOLOGICS INC (HCWB:NASDAQ) absolute price change since previous trading day?
The absolute price change of HCW BIOLOGICS INC (HCWB:NASDAQ) since the previous trading day is $0.018.
HCW BIOLOGICS INC (HCWB:NASDAQ) percentage price change since previous trading day?
The percentage price change of HCW BIOLOGICS INC (HCWB:NASDAQ) since the previous trading day is 4.2959%.
What is the most recent average sentiment score for HCW BIOLOGICS INC (HCWB:NASDAQ)?
The most recent average sentiment score for HCW BIOLOGICS INC (HCWB:NASDAQ) is 81 out of 100.
What is the most recent average sentiment for HCW BIOLOGICS INC (HCWB:NASDAQ)?
The most recent sentiment for HCW BIOLOGICS INC (HCWB:NASDAQ) is .
SEC-8K** Filing Available For HCW BIOLOGICS INC (HCWB:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.